Table 7 Multivariate analysis for overall survival (OS) in Subgroup A and Subgroup C
OS | |||||
|---|---|---|---|---|---|
Parameter | SE | HR | 95% CI | Wald’s p | |
Subgroup A(1st line, chemo-naïve) | |||||
Gender | |||||
Women vs. Men | −0.586 | 0.315 | 0.557 | 0.300-1.033 | 0.063 |
Histology | |||||
Other vs. adenoCa | 0.378 | 0.201 | 1.459 | 0.984-2.164 | 0.060 |
Treatment | |||||
Platinum vs. taxanes | −0.306 | 0.272 | 0.736 | 0.432-1.255 | 0.260 |
tax/plat vs. taxanes | −1.098 | 0.233 | 0.334 | 0.211-0.527 | <0.0001 |
Other vs. taxanes | −0.086 | 0.417 | 0.918 | 0.405-2.079 | 0.837 |
Subgroup C (Chemo-naïve, 1st line and non-relapsed adjuvant) | |||||
Gender | |||||
Women vs. Men | −0.552 | 0.311 | 0.576 | 0.313-1.058 | 0.075 |
Stage | |||||
IIIb-IV vs. I-IIIa | 1.224 | 0.267 | 3.399 | 1.136-2.576 | <0.0001 |
Histology | |||||
Other vs. adenoCa | 0.549 | 0.203 | 1.731 | 1.136-2.576 | 0.007 |
Treatment | |||||
Platinum vs. taxanes | −0.174 | 0.271 | 0.840 | 0.494-1.430 | 0.522 |
tax/plat vs. taxanes | −0.647 | 0.247 | 0.524 | 0.323-0.849 | 0.009 |
other vs. taxanes | 0.042 | 0.415 | 1.043 | 0.463-2.350 | 0.920 |